Cetuximab Completed Phase 2 Trials for Neoplasms, Colorectal Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00055419A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
NCT01152437A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer